Thipparat Suwanmanee

516 total citations
10 papers, 399 citations indexed

About

Thipparat Suwanmanee is a scholar working on Molecular Biology, Genetics and Genetics. According to data from OpenAlex, Thipparat Suwanmanee has authored 10 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Genetics and 2 papers in Genetics. Recurrent topics in Thipparat Suwanmanee's work include Virus-based gene therapy research (4 papers), RNA modifications and cancer (3 papers) and CRISPR and Genetic Engineering (3 papers). Thipparat Suwanmanee is often cited by papers focused on Virus-based gene therapy research (4 papers), RNA modifications and cancer (3 papers) and CRISPR and Genetic Engineering (3 papers). Thipparat Suwanmanee collaborates with scholars based in United States, Thailand and Norway. Thipparat Suwanmanee's co-authors include Suthat Fucharoen, Ryszard Kole, Halina Sierakowska, Tal Kafri, Saovaros Svasti, Tong Gui, Paul E. Monahan, Haibo Wang, M. Elizabeth Hartnett and Hong M. Moulton and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Scientific Reports.

In The Last Decade

Thipparat Suwanmanee

9 papers receiving 386 citations

Peers

Countries citing papers authored by Thipparat Suwanmanee

Since Specialization

Citations

This map shows the geographic impact of Thipparat Suwanmanee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thipparat Suwanmanee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thipparat Suwanmanee more than expected).

Fields of papers citing papers by Thipparat Suwanmanee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thipparat Suwanmanee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thipparat Suwanmanee. The network helps show where Thipparat Suwanmanee may publish in the future.

Co-authorship network of co-authors of Thipparat Suwanmanee

This figure shows the co-authorship network connecting the top 25 collaborators of Thipparat Suwanmanee. A scholar is included among the top collaborators of Thipparat Suwanmanee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thipparat Suwanmanee. Thipparat Suwanmanee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Intravenously administered LV-169 delivers a functional BCMA-CAR transgene to niche-resident T cells and leads to elimination of disseminated myeloma in MHC-deficient NSG mice 2025 ·Blood ·Stephen J. Russell, (unknown), Nandakumar Packiriswamy, Timothy S. Carey, (unknown), (unknown), (unknown), (unknown), (unknown), Hamid Salimi, Thipparat Suwanmanee, D. Phung, Karina Krotova, Rianna Vandergaast, (unknown), Edward L. Briercheck, Eric L. Smith, (unknown), Kah-Whye Peng	0
2	Superior lentiviral vectors designed for BSL-0 environment abolish vector mobilization 2018 ·Gene Therapy ·Peirong Hu, (unknown), Hong Ma, Thipparat Suwanmanee, (unknown), (unknown), Donald B. Kohn, Tal Kafri	12
3	Targeted Knockdown of Overexpressed VEGFA or VEGF164 in Müller cells maintains retinal function by triggering different signaling mechanisms 2018 ·Scientific Reports ·(unknown), Haibo Wang, (unknown), Thipparat Suwanmanee, Gregory J. Stoddard, Tal Kafri, M. Elizabeth Hartnett	33
4	Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy 2018 ·Angiogenesis ·(unknown), Colin A. Bretz, Haibo Wang, (unknown), (unknown), (unknown), Zhihong Yang, Thipparat Suwanmanee, Tal Kafri, M. Elizabeth Hartnett	43
5	Toward Personalized Gene Therapy: Characterizing the Host Genetic Control of Lentiviral-Vector-Mediated Hepatic Gene Delivery 2017 ·Molecular Therapy — Methods & Clinical Development ·Thipparat Suwanmanee, Martin T. Ferris, Peirong Hu, Tong Gui, Stephanie A. Montgomery, Fernando Pardo-Manuel de Villena, Tal Kafri	13
6	Employing a Gain-of-Function Factor IX Variant R338L to Advance the Efficacy and Safety of Hemophilia B Human Gene Therapy: Preclinical Evaluation Supporting an Ongoing Adeno-Associated Virus Clinical Trial 2014 ·Human Gene Therapy ·Paul E. Monahan, Junjiang Sun, Tong Gui, (unknown), (unknown), David Wichlan, Zhijian Wu, Joshua C. Grieger, Chengwen Li, Thipparat Suwanmanee, Darrel W. Stafford, Carmen J. Booth, Jade Samulski, Tal Kafri, Scott McPhee, R. Jude Samulski	86
7	Integration-deficient Lentiviral Vectors Expressing Codon-optimized R338L Human FIX Restore Normal Hemostasis in Hemophilia B Mice 2013 ·Molecular Therapy ·Thipparat Suwanmanee, (unknown), Tong Gui, Cynthia C. Bartholomae, (unknown), Christof von Kalle, Manfred Schmidt, Paul E. Monahan, Tal Kafri	37
8	RNA repair restores hemoglobin expression in IVS2–654 thalassemic mice 2009 ·Proceedings of the National Academy of Sciences ·Saovaros Svasti, Thipparat Suwanmanee, Suthat Fucharoen, Hong M. Moulton, Michelle H. Nelson, Nobuyo Maeda, Oliver Smithies, Ryszard Kole	61
9	Restoration of Human β-Globin Gene Expression in Murine and Human IVS2–654 Thalassemic Erythroid Cells by Free Uptake of Antisense Oligonucleotides 2002 ·Molecular Pharmacology ·Thipparat Suwanmanee, Halina Sierakowska, Giuseppina Lacerra, Saovaros Svasti, Suzanne L. Kirby, Christopher Walsh, Suthat Fucharoen, Ryszard Kole	54
10	Repair of a Splicing Defect in Erythroid Cells from Patients with β-Thalassemia/HbE Disorder 2002 ·Molecular Therapy ·Thipparat Suwanmanee, Halina Sierakowska, Suthat Fucharoen, Ryszard Kole	60

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact